Jp. Usenius et al., CHOLINE-CONTAINING COMPOUNDS IN HUMAN ASTROCYTOMAS STUDIED BY H-1-NMRSPECTROSCOPY IN-VIVO AND IN-VITRO, Journal of neurochemistry, 63(4), 1994, pp. 1538-1543
We have studied 14 patients with different grades of astrocytomas usin
g H-1 NMR spectroscopy in vivo. Typically, astrocytomas exhibited a lo
w N-acetyl-aspartate peak, a prominent signal from choline group-conta
ining compounds, and lactate in the H-1 NMR spectra in vivo. The uncor
rected choline/creatine + phosphocreatine peak area ratios were higher
in tumors than in normal brain tissue. Absolute concentration of chol
ine-containing compounds (1.74 +/- 0.09 mmol/L) in the normal brain ti
ssue was not different in any grade of astrocytoma, but total creatine
concentration in healthy brain (7.49 +/- 0.30 mmol/L) was higher than
that in grade IV astrocytomas (4.84 +/- 0.89 mmol/L). Relaxation cons
tants of choline-containing compounds did not differ in tumors from th
ose determined in normal brain. Perchloric acid extracts of biopsy sam
ples from 35 astrocytomas and 13 samples of normal temporal white matt
er were analyzed with H-1 NMR. Total concentration of choline-containi
ng compounds did not differ between controls and any grade of astrocyt
oma when the quantification was done in vitro. It is interesting that
phosphorylcholine concentration was about twofold greater in grade IV
astrocytomas than in controls or other grades of astrocytomas. We conc
lude that high phosphorylcholine in grade IV astrocytomas may be an in
dicator of degree of malignancy. The proportional changes within the g
roup of choline-containing compounds observed in vitro were not reflec
ted in the NMR properties of choline signal in vivo.